TGFB1 and Hepatic fibrosis: Specifically, enhanced STAT1 activation in hepatic non-parenchymal cells, particularly in HSCs, has been related to the inhibition of HSC proliferation, reduction in TGF-β signaling, and stimulation of NK cell killing of activated HSCs, all of which attenuate liver fibrosis [4].